Expansion Therapeutics Names Sudhir Rao Senior Vice President of Business Development

News
2022
2021
Archive

November 19, 2021

Arvinas and Pfizer Announce Updated Phase 1 Dose Escalation Data for ARV-471 to be Presented in Spotlight Poster Session at 2021 San Antonio Breast Cancer Symposium
November 17, 2021

Novome Biotechnologies Reports Positive Results from a Phase 1 Study of NOV-001
November 16, 2021

Thimble Point and Pear Therapeutics Announce Additional $50 Million in Committed Capital to Fund Business Plan
November 10, 2021

Crinetics Pharmaceuticals Presenting New Data From Open Label Extension Trial of Paltusotine in Acromegaly at the Society for Endocrinology BES Congress
November 10, 2021

Nouscom to Present Interim Data From Phase 1 Trial Evaluating NOUS-209, an “Off-The-Shelf” Neoantigen Cancer Vaccine for the Treatment of MSI-H Solid Tumors
November 10, 2021

Pear Therapeutics Announces Inclusion of reSET® and reSET-O® on the November 2021 MassHealth Drug List Summary Update and MassHealth Non-Drug Product List
November 10, 2021

Novome Biotechnologies and Genentech Enter into a Strategic Collaboration to Develop Targets Against Inflammatory Bowel Disease
November 8, 2021

Akouos Appoints Stacy Price as Chief Technical Officer
November 4, 2021

NodThera Announces Progress of NT-0796, a Novel NLRP3 Inflammasome Inhibitor, into a Phase 1 First-in-Human Study
November 2, 2021

Cabaletta Bio Reports Clinical Data from the Third Dose Cohort in DesCAARTes™ Trial in Patients with mPV

© 2022 5AM Venture Management LLC